10.09.2019 • NewsBrenntagElaine Burridge

Brenntag to Convert into European Company

“Brenntag is an international group headquartered in Europe and employing...
“Brenntag is an international group headquartered in Europe and employing people from over 100 nations, of whom 90 percent work outside Germany,” said CEO Steven Holland

Leading chemical distributor Brenntag has announced plans to convert from a German stock corporation into a European company, or Societas Europaea (SE). The group is currently a stock corporation under German law.

“Brenntag is an international group headquartered in Europe and employing people from over 100 nations, of whom 90 percent work outside Germany,” said CEO Steven Holland. “The SE as a supranational legal form stands for our global orientation and identity and the transformation is a consistent step in the further development of our company.”

Both Brenntag’s management and supervisory boards have decided on the move, which will see the company continue to be headquartered in Essen and governed on a dual basis by the two boards. The responsibilities and composition of the two bodies will not be affected by the new legal structure, Brenntag said.

The conversion is expected to take effect in the summer of 2020; it will be submitted for approval at the company’s general shareholders’ meeting in June 2020.

Shareholders of Brenntag AG will automatically become shareholders in Brenntag SE. The conversion will not affect the company’s listing on the Frankfurt Stock Exchange.

Company

Logo:

Brenntag SE

Messeallee 11
45131 Essen
Netherlands

Company contact







Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.